Teleflex (TFX)
Builds medical devices for vascular access, interventional, and surgical procedures.
$124.90
After hours−0.02 (−0.02%)
At close$124.92(+0.10%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Oct 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 746 | 774 | 738 | 750 | 764 | 795 | 701 | 781 | 913 | 569 | 548 | 570 |
| Cost of revenue | 330 | 342 | 322 | 333 | 334 | 355 | 311 | 350 | 461 | 262 | 241 | 239 |
| Gross profit | 416 | 431 | 416 | 416 | 430 | 440 | 389 | 431 | 452 | 307 | 307 | 332 |
| 251 | 349 | 421 | 300 | 281 | 550 | 264 | 276 | 481 | 271 | 287 | 271 | |
| Research & development | 38 | 36 | 37 | 41 | 39 | 45 | 36 | 39 | 57 | 49 | 44 | 45 |
| 213 | 261 | 243 | 251 | 247 | 255 | 223 | 215 | 282 | 222 | 226 | 214 | |
| Selling & marketing | 0 | 0 | −138 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 0 | 0 | 381 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 214 |
| Other expenses | 0 | 52 | 141 | 8 | −5 | 251 | 5 | 22 | 142 | 0 | 17 | 13 |
| Operating income | 165 | 82 | −5 | 117 | 149 | −110 | 126 | 155 | −30 | 36 | 20 | 60 |
| −16 | −22 | −21 | −19 | −19 | −16 | −17 | −20 | −409 | −49 | −24 | −15 | |
| Interest income | 7 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 |
| Interest expense | 23 | 26 | 23 | 21 | 21 | 19 | 19 | 22 | 38 | 28 | 26 | 28 |
| Other non-operating income | −7 | −3 | −2 | −2 | −2 | −2 | −2 | −2 | 371 | 21 | 48 | −13 |
| Income before tax | 150 | 60 | −26 | 97 | 131 | −127 | 109 | 135 | −439 | −12 | −4 | 45 |
| Income tax expense | 12 | 29 | −42 | 17 | 20 | 10 | 14 | 13 | −30 | −9 | 1 | 3 |
| Net income from continuing operations | 138 | 31 | 16 | 80 | 111 | −137 | 95 | 123 | −409 | −4 | −5 | 42 |
| Discontinued operations | −1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −711 | −3 | 60 |
| Net income | 137 | 31 | 15 | 80 | 111 | −137 | 95 | 123 | −409 | −714 | −8 | 102 |
| EPS, basic | $2.92 | $0.66 | $0.32 | $1.70 | $2.38 | −$2.95 | $2.08 | $2.77 | −$9.24 | −$16.15 | −$0.18 | $2.29 |
| EPS, diluted | $2.90 | $0.66 | $0.32 | $1.69 | $2.36 | −$2.95 | $2.07 | $2.77 | −$9.24 | −$16.15 | −$0.18 | $2.28 |
| Weighted average shares, basic | 47 | 47 | 47 | 47 | 47 | 46 | 46 | 46 | 44 | 44 | 44 | 44 |
| Weighted average shares, diluted | 47 | 47 | 47 | 47 | 47 | 46 | 46 | 46 | 44 | 44 | 44 | 44 |
| EBITDA | 230 | 150 | 63 | 187 | 220 | −36 | 195 | 223 | −323 | 16 | −4 | 73 |
| Depreciation & amortization | 58 | 64 | 66 | 68 | 69 | 72 | 67 | 66 | 78 | 0 | 24 | 0 |
| EBIT | 173 | 86 | −3 | 119 | 152 | −108 | 127 | 157 | −401 | 16 | −28 | 73 |
